{"id":70789,"date":"2026-05-12T11:08:40","date_gmt":"2026-05-12T11:08:40","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=70789"},"modified":"2026-10-15T10:33:57","modified_gmt":"2026-10-15T10:33:57","slug":"ahk-cu","status":"publish","type":"product","link":"https:\/\/medsbase.com\/it\/product\/ahk-cu\/","title":{"rendered":"AHK-Cu"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Risposta rapida \u2014 Cos'\u00e8 AHK-Cu?<\/h3>\n<p style=\"margin: 0;\"><strong>AHK-Cu<\/strong> (Complesso Alanyl-Histidyl-Lysine Copper(II)) \u00e8 un tripeptide sintetico legante il rame e la molecola sorella di <a href=\"https:\/\/medsbase.com\/it\/ghk-cu\/\">GHK-Cu<\/a>. While GHK-Cu is the canonical skin and wound-healing copper peptide, AHK-Cu&#8217;s signal is concentrated in <strong>biologia del follicolo pilifero<\/strong> \u2014 published preclinical work documents stimulation of dermal papilla cells, follicular enlargement, increased follicular vascularization, and prolongation of the anagen growth phase. Supplied in 20\u00a0mg and 50\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Cosa ottieni con MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/it\/reviews\/\">recensioni dei clienti<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Ogni ordine \u00e8 coperto dalla nostra <a href=\"https:\/\/medsbase.com\/it\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica di Garanzia di Rispedizione<\/strong><\/a> \u2014 se il tuo pacco non arriva entro 20 giorni lavorativi, lo rispediamo.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Specifiche<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Dettaglio<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Numero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">110374-12-4 (AHK-Cu); 71567-06-1 (peptide libero AHK)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Formula Molecolare<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>15<\/sub>H<sub>25<\/sub>CuN<sub>6<\/sub>O<sub>4<\/sub> (complesso di rame 1:1)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso molecolare<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">~417 Da (complesso di rame)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequenza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Ala-His-Lys (AHK, 3 amminoacidi) coordinati a un singolo Cu<sup>2+<\/sup> Complesso rame-peptide liofilizzato (polvere da blu a blu-viola; il colore deriva dalle transizioni d-d del Cu legato)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Acqua batteriostatica (consigliata) o acqua sterile per finestre d'uso pi\u00f9 brevi. Solubile in acqua; la soluzione disciolta mantiene il caratteristico colore blu del Cu legato<sup>2+<\/sup>)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Purezza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificato con HPLC, COA disponibile su richiesta)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Conservazione<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizzato: 2\u20138 \u00b0C (frigorifero) per lo stock di lavoro; \u221220 \u00b0C per lo stoccaggio a lungo termine di flaconcini non aperti. Ricostituito: 2\u20138 \u00b0C, utilizzare entro ~30 giorni. Proteggere dalla luce. Non congelare e scongelare la soluzione ricostituita.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilit\u00e0<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Acqua batteriostatica (consigliata) o acqua sterile per finestre d'uso pi\u00f9 brevi. Solubile in acqua; la soluzione disciolta mantiene il caratteristico colore blu del Cu legato<sup>2+<\/sup>.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>(Complesso di Alanyl-Histidyl-Lysine Copper(II)) \u00e8 un tripeptide sintetico legante il rame composto dai tre amminoacidi Ala, His e Lys, coordinati a un singolo ione Cu. \u00c8 la molecola sorella del pi\u00f9 ampiamente studiato<\/h2>\n<p><strong>AHK-Cu<\/strong> (Complesso di rame(II) Alanyl-Histidyl-Lysine) \u00e8 un tripeptide sintetico legante il rame composto dai tre amminoacidi Ala, His e Lys, coordinato a un singolo Cu<sup>2+<\/sup> La composizione molecolare ben caratterizzata \u00e8 C <a href=\"https:\/\/medsbase.com\/it\/ghk-cu\/\">GHK-Cu<\/a> \u2014 both belong to the &#8220;copper peptide&#8221; class, both share the same Cu-coordination architecture using a histidine residue, and both are studied in dermatological contexts. Where they diverge is in primary signal: GHK-Cu is the canonical peptide for skin remodelling, wound healing, and connective-tissue repair, while AHK-Cu&#8217;s most-cited applications are in <strong>biologia del follicolo pilifero<\/strong>. The well-characterised molecular composition is C<sub>15<\/sub>H<sub>25<\/sub>CuN<sub>6<\/sub>O<sub>4<\/sub>, peso molecolare circa 417 Da. Il Cu<sup>2+<\/sup> ion coordinates with the tripeptide via the imidazole nitrogen of histidine, the amino terminus of alanine, and the deprotonated peptide nitrogen between Ala and His \u2014 the same square-planar coordination geometry as in GHK-Cu. The bound copper gives both compounds their characteristic blue-to-violet colour in solid and dissolved form \u2014 users reconstituting AHK-Cu should expect a visibly blue working solution. AHK-Cu is supplied as a high-purity lyophilized copper-peptide complex for reconstitution with bacteriostatic water. The compound is <strong>dalla FDA, EMA, MHRA o da qualsiasi altro importante regolatore per uso terapeutico umano. Il DSIP di grado di ricerca venduto qui \u00e8 fornito<\/strong> by the FDA, EMA, MHRA, or any other major regulator for human therapeutic use. For the sister skin-studies copper peptide, see our <a href=\"https:\/\/medsbase.com\/it\/ghk-cu\/\">GHK-Cu<\/a> pagina prodotto. <\/p>\n<h2>Meccanismo d'azione - Apporto di rame alle cellule della papilla dermica del follicolo pilifero<\/h2>\n<p>Ci\u00f2 che rende l'AHK-Cu meccanicamente distintivo tra i peptidi di rame \u00e8 la sua <strong>segnale preferenziale alle cellule della papilla dermica<\/strong> in the hair follicle \u2014 the mesenchymal cells at the base of each follicle that regulate hair-shaft production and cycle through the growth (anagen), regression (catagen), and rest (telogen) phases. Published studies has documented three principal mechanisms:<\/p>\n<ul>\n<li><strong>Apporto di rame alle cellule della papilla dermica<\/strong> - Lo ione Cu<sup>2+<\/sup> ion is the active payload of AHK-Cu (and of GHK-Cu in skin studies). The tripeptide is a vehicle that ferries the metal ion into target tissue, where copper participates in multiple enzyme cofactor roles including lysyl oxidase (collagen and elastin cross-linking) and superoxide dismutase (oxidative-stress buffering). At the hair follicle, dermal papilla cells take up copper from AHK-Cu and use it to support the follicular extracellular matrix and oxidative-stress management that anagen requires.<\/li>\n<li><strong>Upregolazione del VEGF e vascolarizzazione follicolare<\/strong> \u2014 L'AHK-Cu stimola l'espressione del fattore di crescita endoteliale vascolare (VEGF) nelle cellule della papilla dermica. L'effetto a valle \u00e8 un aumento della perfusione follicolare \u2014 crescita di nuovi capillari alla base del follicolo che supporta le esigenze metaboliche dei cheratinociti della matrice pilifera in rapida proliferazione durante l'anagen. Questo meccanismo di potenziamento della perfusione si sovrappone a quello del minoxidil ma opera attraverso una via fondamentalmente diversa (segnalazione diretta del peptide di rame piuttosto che modulazione dei canali del potassio sensibili all'ATP).<\/li>\n<li><strong>Prolungamento della fase anagen e ingrandimento follicolare<\/strong> \u2014 In published rodent hair-cycle studies, AHK-Cu administration prolongs the duration of the anagen growth phase and increases overall follicular size. The combined effect is more hair-shaft production per follicle per cycle. The mechanism appears to be downstream of the copper-delivery and VEGF-upregulation steps \u2014 healthy, well-perfused follicles in a copper-replete environment sustain anagen for longer before transitioning to catagen.<\/li>\n<\/ul>\n<p>The mechanism is fundamentally different from the two FDA-approved hair-loss compounds: finasteride blocks 5-alpha-reductase to lower scalp DHT (hormonal mechanism); minoxidil opens ATP-sensitive potassium channels to vasodilate follicular vessels (vascular mechanism). AHK-Cu provides direct mesenchymal-cell signalling and copper-cofactor delivery, working at a different point in follicular biology than either FDA-approved compound \u2014 which makes it a useful tool for dissecting follicular cell biology independent of androgen-axis or vasodilation-mediated mechanisms. Subcutaneous, topical, and intrafollicular injection routes are all documented in published studies. <\/p>\n<h2>Published Evidence<\/h2>\n<p>AHK-Cu is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Hair follicle biology studies<\/strong> \u2014 dermal papilla cell proliferation assays, follicular size measurement, hair-shaft diameter analysis, organ-cultured hair follicle studies; canonical copper-peptide compound for the hair-axis (Pyo et al., J Korean Med Sci 2007; Uno &amp; Kurata, J Investig Dermatol)<\/li>\n<li><strong>Hair cycle studies<\/strong> \u2014 durata della fase anagen\/catagen\/telogen, induzione dell'anagen nei follicoli in telogen, risposta dose-risposta comparativa con composti comparatori stabiliti per l'asse pilifero<\/li>\n<li><strong>Follicular vascularization studies<\/strong> \u2014 espressione del VEGF, densit\u00e0 capillare alla base del follicolo, misurazione della perfusione peri-follicolare<\/li>\n<li><strong>Comparative copper peptide studies<\/strong> \u2014 confronto diretto con <a href=\"https:\/\/medsbase.com\/it\/ghk-cu\/\">GHK-Cu<\/a> for dermatological studies; AHK-Cu favoured for hair-axis endpoints, GHK-Cu favoured for skin\/wound\/anti-aging endpoints<\/li>\n<li><strong>Topical and intradermal formulation studies<\/strong> \u2014 AHK-Cu is one of the more-studied copper peptides for topical and intradermal delivery; published studies investigates skin-penetration depth, follicular targeting via different vehicle formulations<\/li>\n<li><strong>Analisi del meccanismo della caduta dei capelli<\/strong> \u2014 alongside finasteride (androgen-axis) and minoxidil (vascular axis), AHK-Cu provides a third orthogonal studies mechanism (mesenchymal-cell + copper-cofactor + VEGF axis); useful for mechanism-of-action studies designs<\/li>\n<li><strong>Collagen and elastin studies<\/strong> \u2014 copper&#8217;s role as cofactor for lysyl oxidase makes copper peptides relevant to studies on extracellular matrix crosslinking; AHK-Cu shares this mechanism with GHK-Cu at the broader level although hair-axis effects predominate.<\/li>\n<\/ul>\n<p>For broader context on where AHK-Cu fits within the copper-peptide and dermatological studies landscape, see <a href=\"https:\/\/medsbase.com\/it\/ghk-cu\/\">GHK-Cu<\/a> as the canonical skin-studies copper peptide, <a href=\"https:\/\/medsbase.com\/it\/bpc-157\/\">BPC-157<\/a> for tissue-repair studies, and <a href=\"https:\/\/medsbase.com\/it\/tb-500\/\">TB-500<\/a> for systemic recovery. Browse the full <a href=\"https:\/\/medsbase.com\/it\/peptides\/\">catalogo peptidi<\/a> per composti correlati. <\/p>\n<h2>Concentrazioni e Dosaggi Disponibili<\/h2>\n<p>MedsBase stocks AHK-Cu in two lyophilized vial sizes calibrated to typical protocol lengths. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats with full reconstitution guidance:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Dosaggio per Flaconcino<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso d'Uso Tipico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Dimensioni della Confezione<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>20 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength \u2014 topical formulation and short-cycle protocols<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 fiale<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>50 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Bulk packs vial, extended cycles, lowest per-mg cost, multi-cohort follicle studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 fiale<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Both strengths are the same chemical form (lyophilized copper-peptide complex, 99%+ HPLC purity). Higher-mg vials are particularly useful for AHK-Cu because of the relatively large doses typical in topical-formulation studies compared with the microgram-range systemic peptides. Higher-mg vials require smaller reconstitution volumes per unit dose. <\/p>\n<h2>Confronto \u2014 AHK-Cu vs GHK-Cu<\/h2>\n<p>AHK-Cu e <a href=\"https:\/\/medsbase.com\/it\/ghk-cu\/\">GHK-Cu<\/a> are sister copper-binding tripeptides that share the same Cu-coordination chemistry but differ in the first amino-acid residue (Ala vs Gly). This minor structural difference produces qualitatively different signals: GHK-Cu dominates skin\/wound\/anti-aging studies while AHK-Cu&#8217;s strongest signal is in hair follicle biology. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Criterio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">AHK-Cu<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">GHK-Cu<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Lunghezza<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">3 amminoacidi (tripeptide)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">3 amminoacidi (tripeptide)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Sequenza<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ala-His-Lys<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Gly-His-Lys<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Coordinazione del rame<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1:1 Cu<sup>2+<\/sup> tramite His + N-terminale<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1:1 Cu<sup>2+<\/sup> tramite His + N-terminale<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Primary signal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Biologia del follicolo pilifero, prolungamento dell'anagen<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Rimodellamento cutaneo, cicatrizzazione, anti-aging<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Tipo di cellula target<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Cellule della papilla dermica (follicolo pilifero)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Fibroblasti dermici, cheratinociti (pelle)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Segnalazione VEGF<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Forte \u2014 vascolarizzazione follicolare<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Moderata \u2014 angiogenesi del letto della ferita<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Occorrenza endogena<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Sintetico (nessun pool endogeno significativo)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Endogeno (diminuisce con l'et\u00e0 nel plasma)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Dosaggio tipico<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">2\u201310 mg topico \/ 1\u20135 mg sottocutaneo<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1\u20135 mg topico \/ 0,5\u20132 mg sottocutaneo<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For hair-axis studies, AHK-Cu is the canonical first choice because of the dermal-papilla-cell selectivity and the documented anagen-prolongation signal. For skin remodelling, wound healing, and anti-aging studies, <a href=\"https:\/\/medsbase.com\/it\/ghk-cu\/\">GHK-Cu<\/a> is the canonical reference. Some studies designs use both in parallel arms to dissect copper-peptide effects that are shared (general Cu cofactor delivery) from effects that are sequence-specific (cell-type selectivity). <\/p>\n<h2>Conservazione e ricostituzione<\/h2>\n<p><strong>Prima della ricostituzione:<\/strong> conservare i flaconcini liofilizzati refrigerati a 2\u20138 \u00b0C nella confezione originale per lo stock di lavoro a breve termine. Per lo stoccaggio a lungo termine non aperto, congelare a \u221220 \u00b0C. AHK-Cu liofilizzato \u00e8 stabile sotto refrigerazione fino a 24 mesi e a \u221220 \u00b0C fino a 36 mesi. Evitare cicli di congelamento-scongelamento sulla polvere liofilizzata. Il coordinamento del Cu<sup>2+<\/sup> \u00e8 stabile nella forma liofilizzata; una volta ricostituito, l'esposizione prolungata alla luce o agli agenti riducenti pu\u00f2 influenzare lo stato di ossidazione del rame. <strong>Procedura di ricostituzione:<\/strong> iniettare acqua batteriostatica lungo la parete laterale del flaconcino del peptide (non direttamente sulla torta liofilizzata). Per un flaconcino da 20 mg, 2,0 mL di acqua batteriostatica producono una concentrazione di lavoro di 10 mg\/mL \u2014 0,1 mL fornisce 1 mg; 0,5 mL fornisce 5 mg. Agitare delicatamente \u2014 non <strong>not<\/strong> scuotere \u2014 e attendere 2\u20135 minuti per la completa dissoluzione. Una soluzione correttamente ricostituita dovrebbe essere chiara con il caratteristico colore blu del Cu legato.<sup>2+<\/sup>. Torbidit\u00e0 o precipitato indicano un problema con la ricostituzione; scartare e riprovare. <strong>Dopo la ricostituzione:<\/strong> store refrigerated at 2\u20138\u00a0\u00b0C and use within 30 days for optimal stability. Do not freeze the reconstituted solution \u2014 freeze-thaw cycles degrade peptide integrity. Protect from direct light at all times. For topical formulation studies, AHK-Cu can be incorporated into a wide range of vehicles (creams, gels, serums) for follicle-studies delivery; published vehicle studies includes liposomal and microemulsion formulations for enhanced follicular penetration. <\/p>\n<h2 id=\"faqs\">Domande frequenti<\/h2>\n<h3>What is AHK-Cu used for in studies?<\/h3>\n<p>AHK-Cu is used in studies investigating hair follicle biology, dermal papilla cell proliferation, anagen phase prolongation, follicular vascularization, hair-shaft diameter, comparative copper-peptide pharmacology, topical and intradermal formulation studies, and mechanism-of-action dissection of hair-loss biology distinct from the androgen-axis (finasteride) and vascular (minoxidil) mechanisms. It is the canonical copper-peptide compound for the hair-axis. The pharmaceutical-grade AHK-Cu sold here is <strong>not<\/strong> FDA-approved and is supplied strictly for clinical studies use only. <\/p>\n<h3>In cosa differisce AHK-Cu da GHK-Cu?<\/h3>\n<p>Entrambi sono tripeptidi leganti il rame che condividono la stessa architettura di coordinazione del Cu (mediata da His in rapporto 1:1 con il Cu<sup>2+<\/sup> binding). They differ in the first amino-acid residue \u2014 alanine in AHK-Cu, glycine in GHK-Cu \u2014 producing different cell-type selectivity in published studies. AHK-Cu&#8217;s strongest signal is in dermal papilla cells of the hair follicle; <a href=\"https:\/\/medsbase.com\/it\/ghk-cu\/\">GHK-Cu<\/a>\u2018Il segnale pi\u00f9 forte di \u2018s si osserva nei fibroblasti e nei cheratinociti cutanei. Questi due tipi cellulari vengono spesso studiati in parallelo per distinguere gli effetti condivisi dei peptidi di rame dagli effetti specifici della sequenza. <\/p>\n<h3>What is the typical AHK-Cu dose?<\/h3>\n<p>Published preclinical protocols typically use 1\u20135\u00a0mg per administration for subcutaneous delivery and 2\u201310\u00a0mg for topical formulation studies, given 1\u20133 times daily for 4\u201312 week cycles. A 20\u00a0mg vial reconstituted with 2.0\u00a0mL bacteriostatic water yields 10\u00a0mg\/mL \u2014 0.1\u00a0mL equals 1\u00a0mg, 0.5\u00a0mL equals 5\u00a0mg. <\/p>\n<h3>No. AHK-Cu non \u00e8 approvato dalla FDA, EMA, MHRA o da qualsiasi altro importante ente regolatorio per uso terapeutico umano. I peptidi di rame sono stati incorporati in alcuni prodotti cosmetici nell'ambito dei regolamenti cosmetici, ma AHK-Cu in particolare non ha approvazioni terapeutiche. Tutto l'AHK-Cu venduto da fornitori per uso esclusivo in ricerca \u00e8 destinato a indagini di laboratorio e non deve essere somministrato agli esseri umani.<\/h3>\n<p>No. AHK-Cu is not approved by the FDA, EMA, MHRA, or any other major regulator for human therapeutic use. Copper peptides have been incorporated into some cosmetic products under cosmetic-regulation frameworks, but AHK-Cu specifically has no therapeutic approval. <\/p>\n<h3>Flaconcini liofilizzati: refrigerati a 2\u20138 \u00b0C per scorte di lavoro a breve termine, o \u221220 \u00b0C per lo stoccaggio a lungo termine di flaconcini non aperti. Soluzione ricostituita: refrigerata a 2\u20138 \u00b0C, utilizzare entro 30 giorni. Non congelare la soluzione ricostituita \u2014 i cicli di congelamento-scongelamento degradano il peptide e possono influenzare la coordinazione del rame. Proteggere sempre dalla luce diretta per preservare lo stato di ossidazione del rame.<\/h3>\n<p>Flaconcini liofilizzati: conservare in frigorifero a 2\u20138 \u00b0C per scorte di lavoro a breve termine, o a \u221220 \u00b0C per lo stoccaggio a lungo termine di flaconcini non aperti. Soluzione ricostituita: conservare in frigorifero a 2\u20138 \u00b0C, utilizzare entro 30 giorni. Non congelare la soluzione ricostituita \u2014 i cicli di congelamento-scongelamento degradano il peptide e possono influenzare la coordinazione del rame. Proteggere sempre dalla luce diretta per preservare lo stato di ossidazione del rame. <\/p>\n<h3>How do I reconstitute AHK-Cu?<\/h3>\n<p>Seguire la procedura di ricostituzione sopra indicata. Aggiungere acqua batteriostatica lungo la parete laterale del flaconcino (non direttamente sulla polvere liofilizzata), agitare delicatamente e attendere 2-5 minuti per la completa dissoluzione. Non <strong>not<\/strong> agitare il flaconcino. Una soluzione ricostituita correttamente \u00e8 limpida con il caratteristico colore blu del rame legato<sup>2+<\/sup> \u2014 il colore stesso conferma la corretta ricostituzione e l'intatta coordinazione del rame. Per un flaconcino da 20 mg + 2,0 mL di diluente, la concentrazione di lavoro \u00e8 di 10 mg\/mL. <\/p>\n<h3>Quali dosaggi sono disponibili su MedsBase?<\/h3>\n<p>MedsBase carries AHK-Cu in 20\u00a0mg and 50\u00a0mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis available on request. <\/p>\n<h3>Perch\u00e9 AHK-Cu \u00e8 di colore blu?<\/h3>\n<p>Il caratteristico colore blu-violetto di AHK-Cu (e GHK-Cu) deriva dalle transizioni elettroniche d-d del rame legato<sup>2+<\/sup> nell'ambiente di coordinazione quadrato-planare creato dal residuo di istidina e dallo scheletro peptidico. Il colore \u00e8 un utile indicatore qualitativo della corretta coordinazione del rame \u2014 una soluzione blu correttamente ricostituita conferma l'intatto legame del Cu<sup>2+<\/sup> , mentre una soluzione incolore o pallida indicherebbe perdita o degradazione del rame. Questa caratteristica \u00e8 unica tra i piccoli peptidi \u2014 la maggior parte dei peptidi sintetici produce soluzioni incolori quando ricostituiti. <\/p>\n<h3>Come si confronta AHK-Cu con finasteride o minoxidil?<\/h3>\n<p>The three target hair-loss biology through completely different mechanisms. Finasteride blocks 5-alpha-reductase to lower scalp dihydrotestosterone (DHT) levels \u2014 an androgen-axis mechanism. Minoxidil opens ATP-sensitive potassium channels to vasodilate follicular vessels \u2014 a vascular mechanism. AHK-Cu provides direct copper-cofactor delivery and VEGF-mediated follicular vascularization at the dermal papilla cell level \u2014 a mesenchymal-cell mechanism. The three mechanisms are orthogonal, which makes AHK-Cu a useful tool for studying follicular biology independent of androgen-axis or vasodilation-mediated effects. <\/p>\n<h3>Does AHK-Cu cause side reported effects?<\/h3>\n<p>Published preclinical studies has reported a notably clean safety profile at typical doses, with the main on-target effect being follicular stimulation. Off-target findings can include local injection-site irritation and (with prolonged high-dose topical exposure) modest cutaneous discolouration from copper deposition \u2014 both reversible with discontinuation. Systemic adverse effects from topical applications are rare due to limited transcutaneous absorption. <\/p>\n<h3>Qual \u00e8 l'emivita dell'AHK-Cu?<\/h3>\n<p>In preclinical studies, AHK-Cu has a relatively short plasma half-life (~1\u20132 hours) following subcutaneous administration. The short half-life is offset by retention of bound copper in target tissues \u2014 even after plasma clearance, the copper delivered to dermal papilla cells continues to support follicular biology through its enzyme-cofactor roles. Topical formulations provide sustained local exposure that is more relevant for hair-axis studies than the systemic plasma profile. <\/p>\n<h3>Can AHK-Cu and GHK-Cu be stacked in studies?<\/h3>\n<p>Yes. The two copper peptides target different cell types (dermal papilla for AHK-Cu, dermal fibroblasts for GHK-Cu) and address different studies domains (hair vs skin), so co-administration is not pharmacologically redundant. Study protocols studying combined skin-and-hair endpoints \u2014 for example, comprehensive dermatological remodelling studies \u2014 sometimes use both arms. <\/p>\n<h3>How long does AHK-Cu take to show effects in preclinical studies?<\/h3>\n<p>Acute effects on dermal papilla cell VEGF expression are detectable within 24\u201372 hours in cell-culture studies. Follicular size and anagen-prolongation effects in rodent hair-cycle models typically become statistically significant after 4\u20138 weeks of regular treatment and continue to accrue through 12\u201316 weeks \u2014 matching the natural hair-cycle timeframe. <\/p>\n<h3>Posso ordinare AHK-Cu per la spedizione internazionale?<\/h3>\n<p>S\u00ec. MedsBase spedisce AHK-Cu in tutto il mondo dalla nostra rete dedicata di spedizione di peptidi. Gli ordini contenenti solo peptidi si qualificano per il nostro servizio di spedizione peptidi autonomo. Tutti gli ordini vengono spediti in imballaggi a temperatura controllata con tracciamento completo e sono coperti dal nostro <a href=\"https:\/\/medsbase.com\/it\/medsbase-re-shipment-assurance-policy\/\">Politica di Garanzia di Rispedizione<\/a>. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Hair, Skin, and Tissue-Regeneration Studies<\/h2>\n<ul>\n<li><a href=\"\/it\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Sister copper-binding tripeptide \u2014 canonical skin remodelling and wound-healing compound<\/li>\n<li><a href=\"\/it\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 tissue-regeneration and recovery<\/li>\n<li><a href=\"\/it\/tb-500\/\"><strong>TB-500 (Thymosin Beta-4)<\/strong><\/a> \u2014 Systemic healing fragment \u2014 tissue and vascular recovery<\/li>\n<li><a href=\"\/it\/epitalon\/\"><strong>Epitalon<\/strong><\/a> \u2014 AEDG pineal tetrapeptide \u2014 longevity and circadian rhythm support<\/li>\n<li><a href=\"\/it\/semax\/\"><strong>Semax<\/strong><\/a> \u2014 Nootropic heptapeptide \u2014 CNS compound<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Approfondimenti<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Explore the copper-peptide studies landscape<\/strong><\/p>\n<p style=\"margin: 0;\">Sfoglia l'intera <a href=\"https:\/\/medsbase.com\/it\/peptides\/\"><strong>catalogo peptidi<\/strong><\/a>, con composti correlati per la dermatologia e la rigenerazione tissutale inclusi <a href=\"https:\/\/medsbase.com\/it\/ghk-cu\/\">GHK-Cu<\/a> (sister copper peptide for skin studies), <a href=\"https:\/\/medsbase.com\/it\/bpc-157\/\">BPC-157<\/a> (rigenerazione tissutale), e <a href=\"https:\/\/medsbase.com\/it\/tb-500\/\">TB-500<\/a> (guarigione sistemica).<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Tripeptide di Rame(II) Alanyl-Histidyl-Lysine<br \/>\n\u2705 Molecola sorella del GHK-Cu<br \/>\n\u2705 Hair follicle biology compound<br \/>\n\u2705 Stimolazione delle cellule della papilla dermica, prolungamento dell'anagen<br \/>\n\u2705 Ortogonale ai meccanismi di finasteride\/minoxidil<\/p>\n<p><strong>AHK-Cu<\/strong> contiene un complesso sintetico rame-peptide.<\/p>","protected":false},"featured_media":70940,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6290,5441],"class_list":["post-70789","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-ahk-cu","product_tag-peptide","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product\/70789","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/comments?post=70789"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/media\/70940"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/media?parent=70789"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product_brand?post=70789"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product_cat?post=70789"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product_tag?post=70789"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}